December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Karen Knudsen: Approximately 65% of Americans are behind on cancer screenings
Dec 15, 2024, 11:09

Karen Knudsen: Approximately 65% of Americans are behind on cancer screenings

Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of ACS, shared a recent article by Daniel S. Reuland on LinkedIn:

“When approximately 65% of Americans are behind on cancer screenings—every win matters.

We all know that early detection of colorectal cancer is one of the most effective ways to improve outcomes and save lives. Yet, the real challenge isn’t always awareness—it’s accessibility.

Barriers like complicated processes, inconvenience, or cost often prevent individuals from getting screened. Loving this study, which shows that if you send cancer screenings directly to people’s homes and make them free, they’re three times more likely to complete the task.

Imagine the possibilities to build on this model because every person screened is a life potentially saved.”

Title: Centralized Colorectal Cancer Screening Outreach in Federally Qualified Health Centers – A Randomized Clinical Trial

Authors: Daniel S. Reuland, Meghan C. O’Leary, Seth D. Crockett, Deeonna E. Farr, Renée M. Ferrari, Teri L. Malo, Alexis A. Moore, Connor M. Randolph, Shana Ratner, Lindsay R. Stradtman, Christina Stylianou, Kevin Su, Xianming Tan, Van Tang, Stephanie B. Wheeler and Alison T. Brenner

cancer screenings

Karen E. Knudsen is the Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.

She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute, on 12 external advisory boards for NCI-designated cancer centers and on Exai Bio.

She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.

More posts featuring Karen Knudsen.